We are live on ! Find out more
ICOL

iShares MSCI Colombia ETF

Delisted

ICOL was delisted on the 22nd of August, 2022.

7 hedge funds and large institutions have $1.5M invested in iShares MSCI Colombia ETF in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% less capital invested

Capital invested by funds: $1.5M → $1.5M (-$3K)

13% less funds holding

Funds holding: 87 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

ICOL Hedge Fund Activity: Q2 2017 in Review

7 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in iShares MSCI Colombia ETF (ICOL) for Q2 2017, worth a combined $1.5M — down 0.2% from $1.5M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ICOL and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was UBS Group, adding an estimated $14.1K. The largest seller was Contravisory Investment Management, exiting entirely with an estimated $26K sold.

  • 7 institutional investors held iShares MSCI Colombia ETF (ICOL) as of Q2 2017, down from 8 in Q1 2017.
  • Funds reported $1.5M of iShares MSCI Colombia ETF stock for Q2 2017, down 0.2% quarter-over-quarter.
  • 0 funds opened new iShares MSCI Colombia ETF positions in Q2 2017 and 1 closed out, a net change of -1 holder.
  • The largest iShares MSCI Colombia ETF buyer in Q2 2017 was UBS Group, an estimated $14.1K added.
  • The largest iShares MSCI Colombia ETF seller in Q2 2017 was Contravisory Investment Management, an estimated $26K sold.

Based on aggregated 13F filings for Q2 2017.